CMS Establishes HCPCS code for Ultromics EchoGo ® Heart Failure, Accelerating Access to Precision HFpEF Detection

Ultromics EchoGo ® Heart Failure is the first US Food and Drug Administration (FDA) cleared platform for detecting Heart Failure with Preserved Ejection Fraction (HFpEF), using a single view of an echocardiogram. The platform has the potential to catch disease earlier and get more patients on the pathway to treatment.